Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | SHR6390 |
Trade Name | |
Synonyms | SHR 6390|SHR-6390|Dalpiciclib |
Drug Descriptions |
SHR6390 (dalpiciclib) inhibits CDK4/6, which may lead to cell cycle arrest and tumor growth inhibition (PMID: 30724426). |
DrugClasses | CDK4/6 Inhibitor 13 |
CAS Registry Number | 1637781-04-4 |
NCIT ID | C125899 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Fulvestrant + SHR6390 | Fulvestrant SHR6390 | 0 | 0 |
Letrozole + Pyrotinib + SHR6390 | Letrozole Pyrotinib SHR6390 | 0 | 0 |
SHR6390 | SHR6390 | 4 | 0 |
SHR6390 + Tamoxifen | SHR6390 Tamoxifen | 0 | 0 |